Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality

BiotechReality - Information Intelligence System for Biopharma

  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #Cancer #FDA Approval #Novo Nordisk #Pfizer
Clinical Investigation Gene Therapy News

Mice Show Promise Results in Gene Therapy for Rare Epilepsy

  • By Ajmal Aseem
  • 17 February 2025
dynamic brain

Rare yet debilitating disorders, Dravet syndrome, and other developing epileptic encephalopathies induce a variety of symptoms in children, such as seizures, intellectual incapacity, and even [Read More…]

Tagged Epilepsy, Rare Epilepsy
Research News

Research Finds Out Bacteria Use a Protein Shuttling Mechanism to Discharge Antibiotics

  • By Editor's Desk
  • 16 February 2025
0212 protein

With the mechanism now known, scientists are attempting to sabotage the process with chemical and mechanical means to allow antibiotics to function without hindrance.

Tagged antibiotic resistance, Protein Shuttling
Research Diseases

Latest Research Finds Out New Blood Clotting Disorder

  • By Editor's Desk
  • 15 February 2025
blood cloating disorder

According to the study, even in the absence of established triggers for these antibodies, such as blood thinners (heparin) or previous vaccinations.

Tagged Blood Cloating Disorder
Regulatory Approval Healthcare & Pharmaceuticals News

The FDA has approved GOMEKLI™(mirdametinib) for the treatment of NF1-PN in both adult and pediatric patients, according to SpringWorks Therapeutics

  • By Ajmal Aseem
  • 13 February 2025
SpringWorks genetic disorder drug

The U.S. Food and Drug Administration (FDA) has approved GOMEKLI™ (mirdametinib), SpringWorks Therapeutics, Inc.’s MEK inhibitor, for the treatment of adult and pediatric patients with [Read More…]

Tagged FDA Approval, GOMEKLI
Artificial Intelligence Disease Biology Research

Search for Novel Tuberculosis Drug Targets Accelerated by Artificial Intelligence

  • By Journal Updates
  • 12 February 2025
TB Bacterium 705 2 5 25

A biotech startup that was spun off from UC San Diego uses deep learning to screen for potential antibiotic candidates as a TB outbreak spreads in Kansas.

Tagged Tuberculosis
Weight-loss Drugs News Research

A Drug Can Avoid Osteoporosis and Muscle Loss After Rapid Weight Loss

  • By Editor's Desk
  • 11 February 2025
muscle strength

Rapid weight reduction might raise the risk of osteoporosis and reduce muscular mass. However, there is now excellent news for those who may be at danger when taking weight loss medications. According to a recent study from Aarhus University, the adverse effects can be mitigated by the medication bimagrumab.

Tagged Muscle Loss, Osteopororsis
Diabetes News

Mitochondria Have A Major Role in Curing Diabetes

  • By Ajmal Aseem
  • 9 February 2025
mitochondrial dna

The production of energy that powers cells and facilitates their operation depends on mitochondria. On the other hand, disorders like type 2 diabetes are linked [Read More…]

Tagged Diabetes Cure, Diabetes Mellitus, mitochondria
Virology News Research

Research Finds New Pathway to Fight Viruses

  • By Editor's Desk
  • 8 February 2025
h5 n1 virus

According to the study, a gene found in some bats can cut the SARS-CoV-2 virus’s production by up to 90%, which may pave the way for novel therapeutic strategies to treat viral illnesses.

Tagged Virus
Neuroscience Biochemistry Research

The Two Proteins Involved in Alzheimer’s Disease Have Distinct Effects on Brain Circuitry

  • By Editor's Desk
  • 7 February 2025
AlzhimerNeurones SauraLab webUAB

Using a novel animal model of Alzheimer’s disease, the study raises the possibility of a breakthrough in therapeutic approaches.

Tagged Alzheimer's, Protein Biology
Clinical Trials Cancer Research

Patients With Kidney Cancer in Stages III and IV May Benefit from the Cancer Vaccination

  • By Ajmal Aseem
  • 6 February 2025
cancer in kidney

Surgery to remove the tumor is the standard of care for individuals with stage III or IV clear cell renal cell carcinoma.

Tagged Kidney, Kidney Cancer, Renal Carcinoma

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Samsung Biologics Q2 2026 Earnings: Revenue Rises to KRW 1,321 Billion Amid Global Manufacturing Expansion
Business CDMO Healthcare & Pharmaceuticals Manufacturing News

Samsung Biologics Q2 2026 Earnings: Revenue Rises to KRW 1,321 Billion Amid Global Manufacturing Expansion

24 July 202624 July 2026
Editor's Desk
Danaher Corporation Q2 2026 Financial Results; Strategic Capital Allocation, and Market Valuation Dynamics
Business Healthcare & Pharmaceuticals News

Danaher Corporation Q2 2026 Financial Results; Strategic Capital Allocation, and Market Valuation Dynamics

23 July 202623 July 2026
BiotechReality Business Intelligence Desk
Novartis Q2 2026 Results: Kisqali, Kesimpta, and Pluvicto Drive Return to Sales Growth
Business Healthcare & Pharmaceuticals News

Novartis Q2 2026 Results: Kisqali, Kesimpta, and Pluvicto Drive Return to Sales Growth

22 July 202622 July 2026
BiotechReality Business Intelligence Desk
Novo Nordisk Eli Lilly Lawsuit: Novo Nordisk Sues Eli Lilly Over Misleading Wegovy, Ozempic Ad Comparisons
Legal and Patent Affairs Healthcare & Pharmaceuticals News

Novo Nordisk Eli Lilly Lawsuit: Novo Nordisk Sues Eli Lilly Over Misleading Wegovy, Ozempic Ad Comparisons

21 July 202622 July 2026
Legal and IP Desk
Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN
Regulatory Approval Healthcare & Pharmaceuticals News

Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN

18 July 202617 July 2026
Regulatory Intelligence Desk
LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C
Regulatory Approval Healthcare & Pharmaceuticals News

LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C

17 July 202617 July 2026
Regulatory Intelligence Desk
Advertisement
BiotechReality JobFinder

  • Global Campaign Specialist – Pall Corporation
    23 July 2026
  • Key Account Manager Bioprocess – Cytiva
    20 July 2026
  • Quality Specialist – Thermo Fisher Scientific
    17 July 2026
  • HSE Specialist – Novartis
    17 July 2026
  • Field Application Specialist – Sartorius
    14 July 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter